Related Experiment Video
Updated: Sep 25, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
The cholecystokinin antagonist proglumide enhances the analgesic effect of dihydrocodeine
1Rampark Pain Centre, Lurgan, Northern Ireland, United Kingdom. gary@mccleane.freeserve.co.uk
Aim:
To investigate the potential pro-analgesic effect of the non-specific CCK antagonist proglumide on the analgesia produced by dihydrocodeine.
Method:
A double-blind, placebo-controlled crossover study of 30 adult subjects.
Results:
Mean pain scores fell from a baseline of 8.12-7.89 during the placebo phase (N.S.) and to 6.82 during the proglumide phase (P < 0.05). Side effects were minor.
Conclusion:
The CCK antagonist proglumide enhances the analgesic effect of dihydrocodeine.
Related Concept Videos
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Analgesia and Pain Management
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...